These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 11640868

  • 1. Myeloproliferative disorders.
    Bench AJ, Cross NC, Huntly BJ, Nacheva EP, Green AR.
    Best Pract Res Clin Haematol; 2001 Sep; 14(3):531-51. PubMed ID: 11640868
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular genetics and cytogenetics of myeloproliferative disorders.
    Bench AJ, Nacheva EP, Champion KM, Green AR.
    Baillieres Clin Haematol; 1998 Dec; 11(4):819-48. PubMed ID: 10640219
    [Abstract] [Full Text] [Related]

  • 4. Karyotype and molecular cytogenetic studies in polycythemia vera.
    Andrieux JL, Demory JL.
    Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
    Najfeld V, Cozza A, Berkofsy-Fessler W, Prchal J, Scalise A.
    Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N, Basinko A, Morel F, Le Bris MJ, Ugo V, Morice P, Berthou C, De Braekeleer M.
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [Abstract] [Full Text] [Related]

  • 11. [Karyotyping in chronic myeloproliferative syndrome (except chronic myeloid leukemia)].
    Lessard M.
    Pathol Biol (Paris); 1982 Nov; 30(9):759-65. PubMed ID: 6760079
    [Abstract] [Full Text] [Related]

  • 12. 8p11 myeloproliferative syndrome: a review.
    Jackson CC, Medeiros LJ, Miranda RN.
    Hum Pathol; 2010 Apr; 41(4):461-76. PubMed ID: 20226962
    [Abstract] [Full Text] [Related]

  • 13. Conventional cytogenetics in myelofibrosis: literature review and discussion.
    Hussein K, Van Dyke DL, Tefferi A.
    Eur J Haematol; 2009 May; 82(5):329-38. PubMed ID: 19141119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Molecular diagnosis of chronic myeloproliferative diseases and myelodysplastic syndromes].
    Bock O.
    Verh Dtsch Ges Pathol; 2007 May; 91():140-53. PubMed ID: 18314608
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.